STOCK TITAN

Krystal Biotech Inc - KRYS STOCK NEWS

Welcome to our dedicated news page for Krystal Biotech (Ticker: KRYS), a resource for investors and traders seeking the latest updates and insights on Krystal Biotech.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Krystal Biotech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Krystal Biotech's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.35%
Tags
none
-
Rhea-AI Summary
Krystal Biotech receives FDA approval for VYJUVEK gene therapy for the treatment of dystrophic epidermolysis bullosa (DEB)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.85%
Tags
fda approval
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.05%
Tags
earnings
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.62%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.42%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
none
Krystal Biotech Inc

Nasdaq:KRYS

KRYS Rankings

KRYS Stock Data

5.01B
20.43M
13.01%
89.65%
8.88%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Pittsburgh

About KRYS

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)